Security Snapshot

Ardent Health, Inc. - COM (ARDT) Institutional Ownership

CUSIP: 03980N107

13F Institutional Holders and Ownership History from Q3 2024 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

125

Shares (Excl. Options)

106,354,090

Price

$8.83

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / COM
Symbol
ARDT on NYSE
Price per share
$8.56
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
106,354,090
Total reported value
$939,071,099
% of total 13F portfolios
0%
Share change
-165,802
Value change
-$9,658,532
Number of holders
125
Price from insider filings
$8.56
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • ARDT - Ardent Health, Inc. - COM is tracked under CUSIP 03980N107.
  • 125 institutions reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 125 to 76 between Q4 2025 and Q1 2026.
  • Reported value moved from $939,071,099 to $86,735,923.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 125 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 03980N107?
CUSIP 03980N107 identifies ARDT - Ardent Health, Inc. - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 125 institutional investors reported holding 106,354,090 shares of Ardent Health, Inc. - COM (ARDT).

Institutional Holders of Ardent Health, Inc. - COM (ARDT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 10,142,963 $86,735,923 +$10,357,657 $8.56 76
2025 Q4 106,354,090 $939,071,099 -$9,658,532 $8.83 125
2025 Q3 106,648,004 $1,412,932,183 +$28,855,426 $13.25 122
2025 Q2 95,124,915 $1,297,051,809 +$6,932,301 $13.66 109
2025 Q1 94,416,777 $1,297,556,123 +$2,107,016 $13.75 108
2024 Q4 102,844,010 $1,756,353,804 +$8,016,600 $17.08 88
2024 Q3 92,856,920 $1,707,061,863 +$1,696,369,428 $18.38 73
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .